Additionally, the mTOR inhibitor, CCI-779, a rapamycin analog, improved motor phenotypes in HD transgenic HD-N171-N82Q mice and reduced polyQ-HTT aggregate load by inducing autophagy activation [262]. The gene discussed is MTOR; the disease is Huntington disease.